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Diffuse lymphangiomatosis: Are there any clinical or therapeutic
standards?
Charalambos Zisis, MD, PhD, FETCS,a Konstantinos Spiliotopoulos, MD,a Marios Patronis, MD,a George Filippakis, MD,a
Grigoris Stratakos, MD, PhD,b George Tzelepis, MD, PhD,c and Ion Bellenis, MD, PhD, FETCS,a Athens, Greece
One of a variety of clinical disorders representing con-genital developmental malformations of the lym-phatic system, lymphangiomatosis describes the pres-ence of multiple lymphangiomas. It is associated with
other lymphatic abnormalities, and 75% of cases involve multiple
organs. It most commonly presents in childhood, with predilection
for thoracic and neck lesions, with up to 75% of patients having
bony involvement.1
Clinical Summary
A 23-year-old man was referred to our department for a large
left-sided pleural effusion representing a chylothorax as demon-
strated after thoracocentesis. He had had persistent cough for
months without dyspnea or hemoptysis. His medical history in-
cluded small bowel resection at the age of 6 years for acute
intestinal obstruction owing to intestinal lymphangiomatosis. The
computed tomographic scan revealed diffuse abnormal mediasti-
nal, retrocrural, and peritoneal lymphatic tissue with enlarged,
nonhomogeneous spleen (Figure 1).
A drain was initially inserted in the left side of the chest and
drained 2500 mL of chylous effusion. This was followed by
conservative management with nothing by mouth and total paren-
teral nutrition support for 2 weeks. The amount of draining fluid,
however, did not fall to less than 500 mL per day, and a new
computed tomographic scan after 12 days revealed a trapped left
lung with pleural space loculations (Figure 2); thus, a decision was
made to proceed with surgical intervention. Lymphatic cystic
spaces developed in all mediastinal, diaphragmatic, parietal, and
visceral pleurae. Pleural surfaces were fibrous in some positions
and watery in others, with milky fluid flowing throughout. Decor-
tication with parietal, visceral, and diaphragmatic pleurectomy was
performed through a left posterolateral thoracotomy. Fibrin glue
was applied along the posterior mediastinal pleura. Total excision
of the lesion was impossible owing to its diffuse character and
“fluid” substance, preventing the separation of pathologic from
normal structures. The postoperative course was uneventful, drain-
age stopped after the third postoperative day, a normal diet was
established, the chest tube was removed on the sixth postoperative
day, and the patient was discharged 2 days later. The patient is
doing well with no symptoms 6 months later.
Discussion
This patient’s presentation is unusual and unique compared with
that of other patients with lymphangiomatosis because of its con-
troversial nature: on the one hand there is the duration of the
disease, starting as acute intestinal obstruction requiring intestinal
resection when the patient was 6 years old; on the other hand there
is the benign course, as the second clinical manifestation occurred
17 years later with the patient remaining asymptomatic in the
interim! The involvement of both the retroperitoneal space and the
mediastinal compartments in a diffuse pattern is rare and suggests
advanced disease with organ involvement. Paradoxically, in the
case reported, the spleen is affected, whereas the bones and the
lungs are not involved. Chylous pleural effusion and chylopericar-
dium have been reported as manifestations of lymphangiomatosis
in younger patients (early or late childhood), having been attrib-
uted to bone lymphangiomas resulting in progressive lysis of the
bones and replacement with fibrous strands (Gorham’s disease).2
In contrast, the patient profile in the case presented is different, and
the chylothorax originates in pleural involvement.
The involvement of serosal surfaces and viscera has been
described in the past as the most significant adverse prognostic
factor in lymphangiomatosis.3 Although the disease is usually
located in one part of the mediastinum (with a slightly greater
prevalence in the anterior part),3 in our case all compartments are
affected.
Pathophysiologic changes resulting in chylous pericardial or
pleural effusions are not sufficiently known. The onset of this
complication does not seem to depend on the pathologic “burden”
of the disease, the extent of involved tissue, and organs or the age
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doi:10.1016/j.jtcvs.2007.02.005 Figure 1. Peritoneal lymphangiomatosis with enlarged, patchy
affected spleen.
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of the patient. Therefore, treatment cannot be standardized and
decision-making is customized to the particularities of the case.4
Generalized lymphangiomatosis management can be challeng-
ing. Surgical treatment is indicated for complications (such as
chylopericardium and chylothorax) or for biopsy. An important
issue for management of chylous effusions is that there is not one
specific source of chyle that can be stopped through the thoracic
duct ligation; instead, there is a wide abnormal network of lym-
phatic channels. However, the best results have been reported with
pleurectomy, with or without thoracic duct ligation, whereas tho-
racic duct ligation alone was unsuccessful in all cases. Fibrin glue
application may help control lymphatic leakage from exposed
surfaces after pleurectomy.2 Other treatment options include inter-
feron alfa and systemic chemotherapy with limited success, and
radiation in fractioned dose has been promising for patients with
extensive mediastinal disease.5
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Giant cavernous hemangioma of the distal esophagus treated
with esophagectomy
Anthony W. Kim, MD, Robert J. Korst, MD, Jeffrey L. Port, MD, Nasser K. Altorki, MD, and Paul C. Lee, MD, New York, NY
Giant cavernous hemangiomas are rare tumors of theesophagus. In 1976, Feist, Talley, and Hunt1 de-scribed an upper esophageal hemangioma as “gi-ant”; it was preoperatively 4  7 cm and patholog-
ically 12.0  5.0  2.5 cm in size. We present the case of an
asymptomatic 68-year-old woman who had a giant hemangioma
of the distal esophagus. She underwent an esophagectomy with
a gastric pull-up via a left thoracotomy. Her recovery was
unremarkable and she is doing well at 4 months’ follow-up.
Clinical Summary
A 68-year-old asymptomatic woman was found to have an
abnormality on a chest radiograph before cataract surgery. A
follow-up computed tomographic (CT) scan demonstrated a
large lobulated distal esophageal mass with multiple small calcifi-
cations (Figure 1). Endoscopy was negative for mucosal lesion. A
positron emission tomographic (PET) scan revealed that the mass
had a standardized uptake value of 2.0. A transthoracic biopsy of
the lesion demonstrated only blood and fibrinated material. Mag-
netic resonance imaging (MRI) reidentified the lobulated soft
tissue mass in the distal esophagus and described it as a fusiform
lesion involving the esophageal wall, causing narrowing of the
lumen. Neither mediastinal invasion nor lymphadenopathy was
noted. On the basis of the soft tissue signal and the smooth
appearance, the lesion was thought to be a large leiomyoma.
The patient was brought to the operating room where she
underwent a left posterolateral thoracotomy through the sixth
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Figure 2. Mediastinal involvement and loculated cystic spaces of
the left pleural cavity.
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